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Introduction
The view establishing the cell nucleus as a highly structured
organelle, where the confinement of enzymatic reactions to
nuclear sub-domains dictates functional organization, has
gained increasing support (Hall et al., 2003; Sugiyama et al.,
2005; Taddei et al., 2001). At the molecular level, attention has
focused on post-translational modifications affecting DNA-
packaging proteins called histones. Histone post-translational
modifications act sequentially or in combination to form a
histone code that is read by other proteins to bring about
distinct downstream events (Strahl and Allis, 2000). A
chromatin environment with a distinctive biochemical identity
results, for instance, from the concentration of tri-methyl
histone H3-Lys 9 (H3K9me3) in heterochromatin. H3K9
methylation is mediated in part by histone methyl transferase
SUV39H1 (Aagaard et al., 1999; Rea et al., 2000), which
creates high-affinity binding sites for heterochromatin protein
1 (HP1) (Lachner et al., 2001). In addition, constitutive
heterochromatin exhibits a high density of methyl cytosines,
established and maintained by the local recruitment of DNA
methyl transferases (DNMT) (Li, 2002). Like methyl histone,
methyl DNA provides high-affinity binding sites for methyl-
binding-domain proteins (Wade, 2001). Thus, distinctive
combinations of histone and DNA modifications can specify
the functional properties of a chromosomal domain via the
recruitment of effector proteins (Richards and Elgin, 2002).
Constitutive heterochromatin is primarily concentrated
around centromeres in the interphase nucleus. We will refer to
these domains as pericentromeres. Variable amounts of
heterochromatin are found in pericentromeres of different
chromosomes (Miller and Therman, 2000). Cytogenetic
studies have shown that human chromosome 1 contains the
largest block of pericentromeric heterochromatin, followed by
chromosomes 9 and 16, whereas the acrocentric chromosomes
(13,14,15,21,22) contain medium-sized blocks of
heterochromatin at pericentromeres (Lee et al., 1997). Other
human chromosomes like chromosomes 2, 18 and 20 possess
very small blocks of heterochromatin at pericentromeres.
Three different families of satellite sequences comprise these
heterochromatin blocks. For instance, satellite 2 is the main
component of pericentromeres of chromosome 1 and 2,
whereas satellite 3 is the component of pericentromere of
chromosome 9 and one of the components of pericentromeres
of acrocentric chromosomes (Lee et al., 1997). However, aside
Confinement of enzymatic reactions to nuclear and
chromosomal subdomains regulates functional
organization of the nucleus. Aurora-B kinase regulates cell-
cycle-dependent phosphorylation of chromosomal
substrates through sequential localization to a series of sites
on chromosomes and the mitotic spindle. In G2 nuclei,
Aurora-B recruitment to heterochromatin restricts histone
H3S10 phosphorylation to a domain around centromeres
(pericentromeres). However, no intrinsic chromosomal
determinants have been implicated in Aurora-B
recruitment to interphase pericentromeres. Using cyclin B1
as a cell-cycle marker, we found that the great majority of
nuclei exhibiting H3S10 phosphorylated foci were positive
for cyclin B1, thus revealing that H3S10 phosphorylation
arises at pericentromeres during late S phase and persists
in G2. By immunofluorescent in situ hybridization, Aurora-
B and H3S10 phosphorylated foci were found more
frequently at larger pericentromeres than at smaller ones,
revealing a preferential phosphorylation of
pericentromeres, exhibiting a high density of methyl
cytosines. Disruption of DNA methylation inhibited
pericentromeric Aurora-B targeting and H3S10
phosphorylation in G2 nuclei, thus demonstrating the role
of DNA methylation in Aurora-B targeting to
pericentromeres. These results favour the idea that DNA
methylation maintains a local environment essential for
regulating the functional properties of sub-chromosomal
domains during S-G2 progression.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/120/1/101/DC1
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from gene-silencing effects (Richards and Elgin, 2002), the
chromosomal function associated with the size and
composition of heterochromatin blocks at pericentromeres is
unknown.
Several lines of evidence have shown that histone post-
translational modifications can be submitted to cyclic
variations during transcription, the cell cycle, cell
differentiation and tumorigenesis (Bannister and Kouzarides,
2005; Fischle et al., 2003). For instance, highly localized
histone H3S10 phosphorylation correlates with transcriptional
stimulation of euchromatic genes (reviewed by Berger, 2001).
In addition, histone H3S10 phosphorylation was found to mark
pericentromeres in G2 cells and to decorate mitotic
chromosomes (Hendzel et al., 1997), accumulating during G2-
M in synchronized cells (Shelby et al., 2000). Evidence
towards a function of mitotic histone H3 phosphorylation in
chromosome segregation was found in Tetrahymena, fission
yeast and humans (Mellone et al., 2003; Ota et al., 2002; Wei
et al., 1999). So far, the biochemical pathway linking histone
H3 phosphorylation to chromosome segregation has not been
deciphered.
Mitotic phosphorylation of histone H3 at Ser10 is governed
by Aurora-B (Aur-B) (Crosio et al., 2002; Giet and Glover,
2001; Hsu et al., 2000). Although the related kinase Aurora A
(Aur-A) is capable of phosphorylating histone H3S10, mitotic
histone H3 phosphorylation was only reduced when Aur-B
levels, but not Aur-A levels were decreased by RNA
interference (Giet and Glover, 2001; Hsu et al., 2000; Scrittori
et al., 2005). During interphase Aur-B is localized in the
nucleus, while Aur-A localization is restricted to the cytoplasm
(Ducat and Zheng, 2004). Aur-B localization evolves during
mitosis, following the pattern of canonical ‘chromosome
passenger’ proteins and is sequentially nuclear, centromeric,
mid-spindle and midbody associated (Crosio et al., 2002;
Earnshaw and Bernat, 1991; Zeitlin et al., 2001b).
Confinement and trafficking of these enzymes to specific
cellular domains appears to be a key mechanism for regulating
catalytic activity against specific substrates.
Aur-B functions during mitosis to ensure accurate
chromosome segregation and timely cytokinesis (Andrews et
al., 2003; Shannon and Salmon, 2002) via sequential
association with inner centromere domains and spindle
midzone. Consistent with a role of Aur-B in chromosome
stability, Aur-B is frequently overexpressed in cancer (Meraldi
et al., 2004). In vitro experiments have shown that the
vertebrate Aur-B kinase exists in a passenger protein complex
with INCENP (inner centromeric protein), survivin and
borealin (Vagnarelli and Earnshaw, 2004). Depletion of any of
these four proteins generally causes mitotic mislocalization of
the other passengers, resulting in loss of function (Andrews,
2005). In mammals, Aur-B first localizes to pericentromeres in
G2 or even S phase (Crosio et al., 2002; Zeitlin et al., 2001b).
However, the reason behind the affinity of passenger proteins
for pericentromeres has remained obscure. Understanding the
basis for cell-cycle-specific targeting of Aur-B is important for
understanding its role in the regulated progression of
interphase and mitotic events.
In this study, we investigated the initial recruitment and
associated activity of Aur-B on histone H3S10 in human
interphase nuclei. S and G2 markers were used to dissect the
occurrence of H3S10P foci during the cell cycle, and
immunofluorescent in situ hybrdization (immuno-FISH)
approaches were performed to investigate the frequency of
H3S10P and Aur-B foci at specific pericentromeres. Finally,
two approaches leading to DNA demethylation were applied
to unravel the role of DNA methylation in targeting Aur-B to
pericentromeres in G2 cells.
Results
Pericentromeric foci of phosphorylated histone H3S10
colocalize with Aurora-B and fail to appear upon kinase
inhibition
To gain insights into intrinsic chromosomal determinants that
drive Aurora-B (Aur-B) recruitment, we focused on the
detection of local Aur-B activity at pericentromeres in
interphase nuclei, by localizing the phosphorylated form of
histone H3S10 (H3S10P) in interphase nuclei. To facilitate the
analysis of large numbers of nuclei exhibiting pericentromeric
H3S10P foci, we chose the human embryonic carcinoma
NT2/D1 cells for their high proportion of G2-M cells (Fig.
6Ba, ~29%). Immunodetection of phosphorylated histone
H3S10 appeared as compact nuclear foci (Fig. 1Ab, green), in
a subset of interphase NT2 nuclei (for quantification see Fig.
1E). The great majority of H3S10P foci (96%, n=248)
colocalized with foci detected with an antibody against Aur-B
kinase (Fig. 1A, red), in NT2 nuclei exhibiting between 1 and
40 foci. These nuclear foci were always in the vicinity of a
centromere locus (Fig. 1Ad-e), in agreement with a previous
report (Hendzel et al., 1997). Pre-incubation with the
immunizing H3S10P peptide totally abolished staining
obtained with the H3S10P antibody in nuclei exhibiting Aur-
B localization at centromeres (Fig. 1Bb), thus demonstrating
antibody specificity. Competition with the doubly modified
H3K9me3-S10P peptide did not inhibit H3S10P labelling (Fig.
1Cb), although not as many cells exhibited foci compared with
matching controls (Fig. 1Ab,Cb). These results indicate that
the H3S10P antibody is highly specific for recognizing the
phospho-H3S10 epitope, but can also recognize the H3K9me3-
S10P epitope to a certain extent. In any case, focal sites of
H3S10 phosphorylation colocalize with Aur-B at
pericentromeres.
Aur-B was shown to be the kinase responsible for mitotic
phosphorylation of histone H3 at Ser10 (Crosio et al., 2002;
Giet and Glover, 2001; Hsu et al., 2000). To formally assess
whether pericentromeric H3S10P foci result from Aur-B
activity a treatment with VX-680, a potent Aurora kinase
inhibitor (Harrington et al., 2004), was performed on NT2
cells. A 300 nM concentration of VX-680 was sufficient to
inhibit H3S10P foci in all interphase nuclei (Fig. 1F), which
otherwise exhibit foci at a frequency greater than 50% (Fig.
1E). The presence of nuclei exhibiting foci of Aur-B kinase in
VX680-treated population (Fig. 1Fb,c, red) indicated that Aur-
B activity is not necessary for targeting to pericentromeres. In
summary, our results demonstrate (1) Aur-B targeting to
pericentromeres in interphase is not dependant upon its kinase
activity and (2) pericentromeric H3S10P foci are dependant
upon an active Aur-B kinase localized at pericentromeres.
Phosphorylated H3S10 delineates pericentromeres in
late-S-phase cells and persists during G2
H3S10P foci were previously reported to appear primarily
during the G2 phase in HeLa cells (Hendzel et al., 1997). Since
Journal of Cell Science 120 (1)
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NT2 populations exhibit more than 50% H3S10P-positive
nuclei (Fig. 1E) and were estimated with a 29% G2-M content
by flow cytometry analysis (Fig. 6Ba), we asked when H3S10
phosphorylation occurs relative to DNA replication in these
cells. To directly assess H3S10P phosphorylation in S-phase
cells, DNA replication sites were labelled with a pulse of BrdU,
which was then co-detected with H3S10 antibody (Fig. 2A).
Image analysis was carried out to determine the percentage of
double negative nuclei (Fig. 2Aa-c, BrdU–/H3S10P–), single
positive nuclei (Fig. 2Ad-f, BrdU+/H3S10P– and Fig. 2Aj-l,
BrdU–/H3S10P+) and double positive nuclei (Fig. 2Ag-i,
BrdU+/H3S10P+). Among NT2 nuclei, 34% were positive for
both BrdU and H3S10P (Fig. 2Ag-i), whereas 24% were
exclusively positive for BrdU (Fig. 2Ad-f), thus indicating that
more than half of the BrdU-positive nuclei exhibited H3S10P
foci. It should be noted that double positive cells displayed a
late-S-phase replication pattern, consistent with the occurrence
of H3S10P foci in late-S-phase cells (Fig. 2Ah). In addition, a
lower number of H3S10P foci were found per nucleus
exhibiting dual labelling (Fig. 2Ai, 6±2, n=37) compared with
the population exclusively positive for H3S10P (Fig. 2Al,
27±18, n=37). This result is consistent with a progressive
Fig. 1. Pericentromeric foci of
phosphorylated histone H3S10
colocalize with Aurora-B and fail to
appear upon kinase inhibition.
(A) Images of an interphase NT2
nucleus counterstained with DAPI (a)
and labelled with the H3S10P (b,
green), Aur-B (c, red) and centromeric
proteins (d, blue). A merged image
generated with a green mask to
visualize H3S10P foci is shown (e).
(B-D) A peptide competition assay was
performed before immunodetection
with H3S10P peptide (B), H3K9me3-
S10P peptide (C) and an irrelevant
H3S31P peptide (D). (E-F) Control (E)
and VX-680 treated NT2 cells (F) were
counterstained with DAPI (a,c) and
labelled with H3S10P and Aur-B (b,c,
green and red respectively).
Percentages of mitotic cells (labeled M)
and interphase nuclei positive for
H3S10P are indicated below. DAPI-M,
DAPI mask. Bars, 10 m.
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appearance of H3S10P foci at an increasing number of
pericentromere sites from late S to G2 phases. Similar
conclusions were drawn from HeLa cell analysis (data not
shown). Therefore our results support the occurrence of
H3S10P foci at pericentromeres in late-S-phase cells.
To extend our cell-cycle analysis, we co-detected
cyclin B1 together with H3S10P in NT2 nuclei (Fig.
2B). Cyclin B1 accumulates in the cytoplasm of cells
during S phase and persists during G2, prior to nuclear
internalization at mitosis onset (Pines and Hunter,
1991). Nuclei negative for H3S10P (Fig. 2Ba-f, 41.5%)
were predominantly negative for cyclin B1 (Fig. 2Ba-f,
34% of Cyc B1–/H3S10P–). This result is consistent
with a deficiency in H3S10P foci in G1 and early S-
phase cells, as confirmed when detection was
performed on NT2 cells, flow sorted according to their
DNA content (data not shown). Nuclei positive for
H3S10P (Fig. 2Bg-l, 58.5%) were predominantly
positive for cyclin B1 (Fig. 2Bg-l, 54% of Cyc
B1+/H3S10P+). To summarize, the presence of H3S10P
foci in the nucleus correlates to a great extent with the
cytoplasmic accumulation of cyclin B1. Therefore,
these results demonstrate the persistent occurrence of
H3S10P foci at pericentromeres in a great majority of
cells in late S and G2 phases.
Large pericentromeres colocalize more frequently
with H3S10P foci than small pericentromeres
The progressive appearance of H3S10P foci could
reflect sequential H3S10 phosphorylation at specific
chromosomes or reflect a stochastic phosphorylation at
random chromosomes. To distinguish these
possibilities, pericentromeres of individual
chromosomes were co-detected with H3S10P (Fig. 3A-
C) using a two-step immuno-FISH protocol. Image
analysis was performed on image projections
constructed from deconvolved optical sections, to
evaluate colocalization of FISH signals with H3S10P
foci (Fig. 3D, percentage of H3S10P positive
pericentromeres). Chromosome 1 signals were very
frequently phosphorylated in NT2 nuclei exhibiting
H3S10P foci (Fig. 3A,D; 85%). The frequency of a
stochastic phosphorylation at random chromosomes can
be approximated by the fraction specific chromosomes
represent within a nucleus. In NT2, chromosomes 1
represent 6.3% of the total number of chromosomes
(4/63). Thus, the measured frequency is about 15 times
greater than expected for a random model (85%/6.3%),
thus arguing against stochastic phosphorylation at
random chromosomes. Rather, pericentromeres of
chromosome 1 are preferential targets of H3S10
phosphorylation in human cells, as confirmed by the 14-
times-greater measured frequency of the same event in
human diploid primary cultures (59%/4.3%).
To determine whether heterochromatin block size at
pericentromeres is a crucial factor for defining a
chromosome as a frequent site of phosphorylation, we
analyzed human chromosome 9, which possess a
relatively large pericentromere (Lee et al., 1997) and
represent 4.8% (3/63) of the chromosomes in NT2 cells.
The 27% frequency measured for H3S10P-positive
chromosome 9 signals in NT2 nuclei (Fig. 3D, red bar)
was about five times greater (27%/4.8%) than the
Journal of Cell Science 120 (1)
Fig. 2. H3S10P foci are enriched in late S-phase cells and correlate with
cyclin B1 expression. (A) NT2 cells submitted to a short BrdU pulse were
counterstained with DAPI (grey) and labelled with BrdU (green) and H3S10P
(red). Merged images illustrate the four classes of nuclei analyzed:
BrdU–/H3S10P– (c), BrdU+/H3S10P– (f), BrdU+/H3S10P+ (i) and
BrdU–/H3S10P+ (l). The percentage of nuclei falling into each category is
indicated on the right, as well as the number of H3S10P foci (mean ± s.d.).
(B) NT2 cells were counterstained with DAPI (grey) and labelled with cyclin
B1 (Cyc B1, green) and H3S10P (red). Merged images illustrate the four
classes of nuclei analyzed: Cyc B1–/H3S10P– (c), Cyc B1+/H3S10P– (f), Cyc
B1–/H3S10P+ (i), Cyc B1+/H3S10P+ (l). The percentage of nuclei falling into
each category is indicated on the right. Bars, 10 m.
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105DNA methylation promotes Aurora-B targeting
expected frequency for a random model, thus identifying
pericentromeres of chromosome 9 as preferential sites for
histone H3 phosphorylation. To confirm the large-size rule, we
analyzed acrocentric chromosomes 14 and 22, possessing
relatively large heterochromatin block (Lee et al., 1997) at
pericentromeres and representing 7.9% of the chromosomes in
NT2 cells (Fig. 3C-D). As expected, pericentromeres of
chromosomes 14 and 22 (Fig. 3D, pink) were about
three times more frequently phosphorylated than
expected for a random model (25%/7.9%). The
positive correlation between heterochromatin block
size and pericentromeric histone H3 phosphorylation
frequency was further illustrated with the analysis of
chromosomes 18, 20 and 2 (Fig. 3B,D light and dark
green). These chromosomes possess pericentromeres
with small heterochromatic block size (Lee et al.,
1997) and represent respectively 6.3% and 3.2% of
the chromosomes in NT2 cells, respectively. Ratios
obtained between measured and expected
phosphorylation frequencies were close to 1 for
pericentromeres of chromosomes 18 and 20
(7%/6.3%) as well as for chromosome 2 (4%/3.2%),
thus defining these chromosomes as non-preferential
sites for H3S10 phosphorylation. Altogether these
results demonstrate differential frequencies of
pericentromeric histone H3 phosphorylation at
individual chromosomes correlated with
heterochromatin block size, thus identifying a set of
chromosomes with large pericentromeres
(chromosomes 1, 9, 14 and 22) as preferential sites
of histone H3S10 phosphorylation.
Differential frequencies of pericentromeric Aur-
B localization with passenger proteins parallels
H3S10P preferential appearance in interphase
To investigate whether recruitment of Aur-B kinase
was involved in the regulation of differential histone
H3 phosphorylation at pericentromeres, immuno-
FISH was carried out to detect Aur-B and
pericentromeres of chromosomes 1 and 2 (Fig. 4A-
B). Colocalization between Aur-B foci and
pericentromeres of chromosome 1 and 2 was
determined by image analysis in NT2 cells (Fig. 4B).
As previously reported for phosphorylation, many
chromosome 1 signals were positive for Aur-B
kinase in nuclei exhibiting Aur-B foci (Fig. 4B,
purple, 97%), whereas few positive signals were
obtained with chromosome 2 (Fig. 4B, green, 5%).
In summary, Aur-B localization at pericentromeres
is also differentially regulated at individual
chromosomes, paralleling the large-size rule
observed above for the distribution of its catalytic
activity. In agreement with a role of Aur-B in the
regulation of histone H3 phosphorylation at
pericentromeres, we observed that inhibition of Aur-
B targeting at large pericentromeres results in a low
frequency of H3S10P appearance at pericentromeres
in U2-OS cells (data not shown). Therefore, Aur-B
recruitment controls the preferential occurrence of
H3S10P sites.
To assay whether Aur-B activity was associated
with kinase co-activators in interphase, as occurs in mitosis
(Bolton et al., 2002; Honda et al., 2003; Wheatley et al., 2004),
survivin and INCENP were immunodetected in NT2 nuclei
(Fig. 4C-F). At interphase, both survivin and INCENP label
nuclear foci in a subset of nuclei (Fig. 4Cb,Db), whereas in
mitotic cells, the typical passenger protein pattern was
observed for both proteins (see Fig. S1 in supplementary
Fig. 3. Large pericentromeres colocalize more frequently with H3S10P foci than
small pericentromeres. (A-C) Immuno-FISH images display pericentromeres of
human chromosome 1 (A), chromosome 2 (B) and chromosomes 14 and 22 (C)
in NT2 nuclei exhibiting fewer than ten (a-d), or more than ten H3S10P foci (e-
h). Bar, 10 m. (D) Percentage of phospho-H3 positive pericentromeres in
populations of NT2 nuclei exhibiting phospho-H3 foci is shown for seven
human chromosomes, as indicated. The number of FISH signals analyzed is
indicated for each chromosome (with legends).
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material for survivin), as previously reported (Adams et al.,
2001). The great majority of INCENP and survivin foci
colocalize with Aur-B foci in interphase NT2 nuclei (Fig.
4Ed,Fd). As in mitosis, survivin and INCENP are associated
with Aur-B kinase in interphase nuclei, in agreement with the
detection of its catalytic activity at pericentromeres (see above
and Fig. 1) and biochemical observations indicating that these
three proteins always interact (Bolton et al., 2002). In
summary, our results show clear evidence of in situ
colocalization of INCENP and survivin with Aur-B. The
differential frequencies of pericentromeric Aur-B localization
with passenger proteins parallel the preferential appearance of
H3S10P in interphase nuclei.
Heterochromatin composition of large pericentromeres
in interphase nuclei exhibiting less than 10 H3S10P foci
In the search for a sequence-independent factor concentrated
at large pericentromeres when Aur-B was recruited, we
examined the distribution of heterochromatic marks, namely 5-
methylcytosine (5-meC), HP1, H3K9me3 and the doubly
modified epitope H3K9me3-S10P (Fig. 5). Detection of 5-meC
in NT2 nuclei (Fig. 5A) revealed the presence of 7-16 large
accumulations per nucleus (Fig. 5C). In nuclei exhibiting up to
10-15 H3S10P foci, more than 95% of H3S10P foci
colocalized with the largest 5-meC accumulations (Fig. 5C),
indicating that DNA is methylated at large pericentromeres
when H3S10 gets phosphorylated. The heterochromatic
composition of large pericentromeres was confirmed when
HP1, was codetected with H3S10P in NT2 nuclei (Fig. 5B).
Indeed, H3S10P foci colocalized to a great extent with HP1
accumulations in nuclei exhibiting no more than ten H3S10P
foci (Fig. 5Ba-d). Altogether, these results show that
composition of large pericentromeres includes DNA
methylation and HP1, in nuclei exhibiting H3S10
phosphorylation at less than ten pericentromeres.
To investigate the permanence of these heterochromatic
marks, the composition of large pericentromeres was analyzed
by immuno-fluorescence with cell-cycle markers. In nuclei
Journal of Cell Science 120 (1)
Fig. 4. Aur-B foci colocalize more frequently
with large pericentromeres and other
passenger proteins in interphase nuclei.
(A,B) Aur-B colocalizes frequently with
pericentromeres of chromosome 1 in
interphase NT2 nuclei. Aur-B (c, blue) was
immunodetected with pericentromeres of
chromosome 1 (b, pC1, red) in NT2 nuclei,
counterstained with DAPI (a). Percentages of
Aur-B positive pericentromeres in populations
of NT2 nuclei exhibiting Aur-B foci are
shown for chromosomes 1 and 2 (B). The
number of FISH signals analyzed is indicated
for each chromosome (n). (C,D) NT2 cells
counterstained with DAPI (a) were detected
separately with survivin (Cb, green) and
INCENP (Db, green). Both passenger
proteins labelled foci in a subset of interphase
nuclei. (E-F) NT2 cells counterstained with
DAPI (a) were co-detected with survivin and
Aur-B (E) or INCENP and Aur-B (F). Merged
images show that the great majority of foci
detected with survivin or INCENP colocalize
with Aur-B (d). Detection of survivin and
INCENP in mitotic cells follow the typical
passenger protein pattern (see Fig. S1 in
supplementary material for survivin). Bars, 10
m.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
107DNA methylation promotes Aurora-B targeting
Fig. 5. Heterochromatic nature of large pericentromeres in nuclei exhibiting no more than ten H3S10P or Aur-B foci. (A-B) NT2 nuclei
immunodetected with H3S10P (yellow) and 5-meC (red in A) or HP1 (red in B), exhibiting fewer than ten (a-d) or more than ten H3S10P foci
(e-h). (C) Histogram of the total number of 5-meC accumulations, positive (red) or negative (yellow) for H3S10P according to the number of
foci per NT2 nucleus, as displayed in A. (D) Histogram of the percentage of 94 randomly taken NT2 cells exhibiting HP1 accumulations, as
shown in B, according to the presence of pericentromeric H3S10P foci (no foci, fewer than ten foci, at least ten foci). (E,F) H3K9me (red in E)
or H3K9me3-S10P (red in F) foci colocalize with Aur-B (yellow) in NT2 nuclei exhibiting fewer than ten (a-d) or more than ten nuclear foci
(e-h). (G,H) H3S10P-A594 foci (red) colocalize with H3S10P (yellow in G) and H3K9me3S10P (yellow in H) in NT2 nuclei exhibiting fewer
than ten (a-d) or more than ten nuclear foci (e-h). Bars, 10 m.
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exhibiting more than ten H3S10P foci, 5-meC accumulations
were still present and appeared to colocalize with a subset of
H3S10P foci (Fig. 5Ae-h). Accumulations of 5-meC were also
detected in mitotic cells as well as in H3S10P-negative
interphase nuclei (data not shown), thus illustrating the
permanent nature of DNA methylation at pericentromeres
during the cell cycle. By contrast, HP1 appeared as a diffuse
nuclear staining in nuclei exhibiting more than ten H3S10P
foci (Fig. 5Be-h), thus suggesting a dissociation of HP1 from
large pericentromeres in G2 nuclei. The disappearance of
Journal of Cell Science 120 (1)
Fig. 6. 5-Azacytidine-induced
DNA demethylation partially
inhibits Aur-B driven
phosphorylation of histone H3 at
pericentromeres in interphase
nuclei. (A) Images of NT2 nuclei,
control (a) or treated with 5-
azacytidin (b), counterstained with
DAPI and immunodetected with 5-
methylcytosine (green). For
comparison purposes, 5-
methylcytosine images are
displayed with the same dynamic
scale. Nuclear intensity of 5-
methylcytosine signals was
quantified on control and 5-AzaC-
treated populations (c). Histogram
of the integrated intensity per
nucleus for both populations
normalized by the nuclear
integrated intensity of negative
control population (c, third
column, no HCl). Error bars
correspond to s.d. of the analyzed
populations and n corresponds to
the number of analyzed nuclei.
(B) Cell-cycle analysis of
exponentially growing NT2 cells
by flow cytometry. The ModFit LT
software was used to estimate the
percentage of cells with a G1, S
and G2-M content in control (a)
and 5-azacytidin treated
populations (b). (C) Western blot
analysis of whole NT2 extracts
detected with Aur-B (top) and
H3S10P (bottom), in equally
loaded populations of control (lane
1) and 5-AzaC-treated cells (lanes
2 and 3). (D,E) Analysis of cyclin
B1 expression in NT2 cells treated
with 5-AzaC. Representative fields
of views of control (Da) and 5-
AzaC treated NT2 cells (Db)
counterstained with DAPI (insets,
grey) and labelled with cyclin B1
(green) and H3S10P (red). Table
shows the percentages of cyclin B1
and H3S10P positive nuclei (E,
second and third row, respectively)
and of doubly labelled nuclei (E,
fourth row) obtained in control (E,
second column) and in 5-AzaC
treated NT2 cells (E, third
column). The total number of
analyzed cells, n, is indicated. (F,G) Analysis of HS10P and Aur-B expression in NT2 cells treated with 5-AzaC. Representative field of views
of NT2 cells, control (Fa) or treated with 5-AzaC (Fb), counterstained with DAPI (insets, grey) and immunodetected with H3S10P (green) and
Aur-B (red). (G) Table of the percentage of cells exhibiting H3S10P foci and uniform H3S10P labelling obtained in control and in 5-AzaC-
treated NT2 cells. The total number of analyzed cells, n, is indicated. Bars, 10 m.
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HP1 accumulations was only observed in nuclei exhibiting
ten and more H3S10P foci (Fig. 5D, 10 foci, 0% positive)
and not in nuclei negative for H3S10P (Fig. 5D, no foci, 94%
positive), nor in nuclei exhibiting fewer than ten H3S10P foci
(Fig. 5D, <10 foci, 85% positive). Therefore, our data are
consistent with the maintenance of DNA methylation and the
disappearance of HP1 foci in G2 nuclei following H3S10P
appearance at ten large pericentromeres.
To investigate whether disappearance of HP1 foci resulted
from the loss of a mark favouring its binding to chromatin,
H3K9me3 was codetected with Aur-B in NT2 cells (Fig. 5E).
As described above for 5-meC and HP1, large
pericentromeres labelled by Aur-B colocalize with H3K9me3,
in nuclei exhibiting no more than ten Aur-B foci. This result
corroborates the heterochromatic composition of large
pericentromeres in nuclei exhibiting no more than ten Aur-B
foci. Like HP1, H3K9me3 foci could not be detected in nuclei
exhibiting more than ten Aur-B foci (Fig. 5Ee-h), indicative of
a loss of H3K9me3 antigenicity in G2 cells. However, results
obtained by immunofluorescence with the doubly modified
H3K9me3-S10P epitope (Fig. 5-FH), argued against a real loss
of H3K9me3 in interphase nuclei, but rather favour the
hypothesis that the addition of a phosphate group on S10
altered the recognition of K9me3 with the single modification-
specific antibody. Collectively, these results demonstrate that
5-meC, HP1 and H3K9me3 were present at large
pericentromeres at the time Aur-B was recruited and activated,
and highlight the loss of HP1 foci in G2 cells independent of
H3K9me3.
Genomic DNA demethylation by 5-azacytidine inhibits
pericentromeric appearance of H3S10 foci in G2 cells
To investigate whether disruption of one of the cell-cycle
permanent heterochromatic marks at large pericentromeres
could modify the appearance of histone H3 phosphorylation,
we used 5-azacytidine (5-AzaC), which interferes with S-phase
maintenance of DNA methylation. NT2 cells treated with 5-
AzaC at a concentration of 10 M for 24 hours, displayed a
lower 5-meC staining intensity (Fig. 6Ab) compared with
control cells (Fig. 6Aa). Images acquired with similar
conditions were used to assess 5-meC signal intensities
according to negative control cells, for which the essential HCl
step was omitted. Quantification of the nuclear 5-meC signals
showed a decrease in the normalized integrated intensity, from
1.4 (n=46) in the control population to 1.16 (n=20) in the
treated population (Fig. 6Ac). These results highlighted a
significant but not complete depletion of 5-meC signal upon a
24-hour treatment with 5-AzaC, thus indicating that a single
cell cycle is sufficient to induce a decrease in methyl cytosine
level.
Cell-cycle analysis of these populations by flow cytometry
(Fig. 6B) revealed an overall decrease in the S-phase fraction
for populations treated with 5-AzaC (26%, Fig. 6Bb),
compared with the control (34%, Fig. 6Ba), to the benefit of
the G1-phase fraction (50% compared with 37%, Fig. 6B). Our
results are in agreement with previous observations supporting
a G1 cell-cycle arrest (Lavelle et al., 2003). The percentage of
cells with a G2-M DNA content did not seem to be affected in
NT2 cells treated with 5-AzaC for 24 hours (Fig. 6B) or 48
hours (data not shown). In addition, the amount of Aur-B
kinase detected by western blot on NT2 cell extracts was
comparable between 5-AzaC treated samples and a matching
control (Fig. 6C, top), thus indicating that 5-AzaC did not
inhibit Aur-B kinase expression. Consistent with a reduced
Aur-B activity, a small decrease in H3S10P was observed with
treatment with 10 M 5-AzaC (Fig. 6C, bottom).
To further examine cell-cycle progression upon 5-AzaC
treatment, we analyzed cyclin B1 in 5-AzaC treated
populations (Fig. 6D), a late S and G2-M cell-cycle marker
(Pines and Hunter, 1992). In control NT2 nuclei, 61% were
positive for cyclin B1, whereas 59% were positive for cyclin
B1 in the 5-AzaC-treated population (Fig. 6E). This result
demonstrates that a major regulator of the cell cycle is
cytologically normal after 5-azaC treatment, thus confirming
that this treatment does not alter cell-cycle progression during
late S and G2 phases. Collectively, our results argue against a
grossly abnormal cell-cycle progression during the G2 phase.
To determine whether DNA demethylation induced by 5-
azacytidin altered the appearance of Aur-B-mediated histone
H3 phosphorylation, microscopy analysis was carried out in
control and treated NT2 populations (Fig. 6D,F). In several
independent experiments, a great decrease in the percentage of
nuclei exhibiting H3S10P foci (85% decrease in Fig. 6E and
68% decrease in Fig. 6G) was observed in 5-AzaC-treated
populations compared with matching controls, whereas no
systematic difference was observed for the H3S10P-positive
mitotic fraction in the 5-AzaC-treated population (Fig. 6G).
Therefore, our results support a partial inhibition of H3S10P
foci at pericentromeres of cells treated with 5-AzaC. The fact
that cyclin-B1-positive nuclei rarely exhibit H3S10P foci in the
5-AzaC-treated population compared with the control (Fig. 6E,
8% in treated vs 54% in control) indicates that only a minority
of late S and G2 cells exhibit H3S10P foci. Moreover, detection
of Aur-B in 5-AzaC-treated NT2 populations revealed a great
decrease in the number of nuclei exhibiting Aur-B foci
compared with the matching control (Fig. 6G). Altogether,
these results demonstrate that 5-AzaC alters the spatio-
temporal appearance of H3S10P pericentromeric foci in G2
cells, by interfering with Aur-B kinase recruitment at
pericentromeres.
DNMT1 depletion inhibits pericentromeric appearance of
H3S10P foci in G2 cells
To further probe the role of DNA methylation in Aur-B
recruitment and phosphorylation of histone H3 at
pericentromeres, an independent method was used to induce
genomic hypomethylation. DNA methyl transferase 1
(DNMT1) was knocked down using an anti-sense
oligonucleotide (AS), resulting in a decrease of at least 90% in
DNMT1 abundance relative to a matching control (population
transfected with a mismatch oligonucleotide MM, Fig. 7A).
This depletion occurred without significantly affecting Aur-B
or phospho-H3 abundance (Fig. 7B). Microscopic analysis of
Aur-B in DNMT1-AS cells (Fig. 7C-L) showed a 62%
decrease in nuclei with Aur-B foci relative to control cells,
whereas the percentage exhibiting nuclear phospho-H3 foci
was decreased by 38% (Fig. 7H). A diffuse Aur-B staining was
observed in 20% of AS-treated nuclei (Fig. 7Hb, +/–). These
results demonstrate that DNMT1 depletion causes Aur-B
mislocalization and inhibition of pericentromeric H3S10
phosphorylation. Consistent with our previous results, DNMT1
depletion did not inhibit HP1 appearance as nuclear foci (Fig.
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Fig. 7. DNMT1 depletion inhibits Aur-B-mediated histone H3 phosphorylation at pericentromeres. (A) Transfection with antisense
oligonucleotide (AS) resulted in >90% depletion of DNMT1 compared with a mismatched oligonucleotide control (MM). Vimentin was
detected as a loading control in western blots. (B) Reduction in Aur-B and phospho-H3 is not greater than 50% in these populations.
(C-N) Microscopic analysis of Aur-B, phospho-H3 and HP1 in cells transfected with DNMT1-AS and DNMT1-MM oligonucleotides.
(C-G) Aur-B and centromere colocalization in cells transfected with DNMT-MM (C,D) and DNMT1-AS (E-G). Examples of cells without
(C,E labelled –) and with (D,G labelled +) focal accumulations of Aur-B are shown, as was a third population seen in DNMT1-AS-treated cells
that showed a diffuse localization of Aur-B (F, labelled +/–). (H) Histogram summarizing quantification of Aur-B and H3S10P pericentromeric
foci in oligonucleotides-treated cells. In each case the DNMT1-MM population was used as a standard, revealing a 62% and 38% decrease in
DNMT1-AS cells exhibiting Aur-B and phospho-H3 pericentromeric foci, respectively. (I-N) HP1 and centromere colocalization in cells
transfected with DNMT1-MM (I,J) and DNMT1-AS (K,L). Examples of cells exhibiting no focal accumulations of HP1 (I,K labelled –) and
with focal accumulations (J,L labelled +). Bars, 10 m. (M) Histogram represents quantification of cells with focal accumulations of HP1
with DNMT1-MM (blue), set as the standard in comparison with DNMT1-AS (red). Number of analyzed nuclei is reported above. (N)
Histogram of percentage of mitotic cells scored in the DNMT1-MM (blue) and the DNMT1-AS (red) populations. Number of analyzed nuclei
is reported above. 
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7I-M), thus indicating that HP1 was not a dominant
determinant for Aur-B recruitment at pericentromeres.
Contrary to 5-AzaC treatment, a decrease in the percentage of
mitotic cells from 4.2% in the DNMT1-MM population to
2.6% in the DNMT1-AS population was observed (Fig. 7N).
Collectively, our results demonstrate that DNA methylation
promotes Aur-B recruitment to large pericentromeres.
Discussion
Histone post-translational modifications participate in building
up local chromatin environments (Strahl and Allis, 2000). For
instance, pericentromeres form variably sized blocks of
heterochromatin around centromeres, exhibiting SUV39H1-
mediated tri-methyl histone H3-K9, HP1 and methyl cytosine
(Richards and Elgin, 2002). Histone H3S10 phosphorylation
(H3S10P) is found exclusively at pericentromeres of G2 cells,
and spreads to chromosome arms during mitosis (Hendzel et
al., 1997). Our results are consistent with the exclusive
concentration of H3S10P at pericentromeres in late S and G2
cells, and its preferential localization at large pericentromeres
in human cells. Cell-cycle-regulated H3S10P is mediated by
Aurora-B kinase (Aur-B) in mitotic cells (Crosio et al., 2002;
Giet and Glover, 2001; Hsu et al., 2000). Our study provides
evidence that Aur-B activity promotes pericentromeric histone
H3 phosphorylation in interphase cells (Fig. 1E-F) and is most
frequently found at large pericentromeres (Fig. 4B). As a
passenger protein, Aur-B localization in mitosis depends on its
association with other members of the passenger protein
complex (Vagnarelli and Earnshaw, 2004). However, no
chromosomal determinants involved in Aur-B recruitment to
interphase pericentromeres have been identified to date. In this
work, we have used two independent means of inhibiting
genomic DNA methylation to show that DNA demethylation
inhibits Aur-B recruitment and activity at pericentromeres of
interphase nuclei.
The concentration of H3S10P at pericentromeres in late S
and G2 cells, is supported by the facts that more than half of
the cells incorporating BrdU exhibit H3S10P foci (Fig. 2A) and
that the presence of H3S10P foci correlate with cytoplasmic
accumulation of cyclin B1 (Fig. 2B), a late S and G2 marker
(Pines and Hunter, 1992). These results extend previous
observations by Hendzel et al. (Hendzel et al., 1997), by
demonstrating that H3S10P foci located at pericentromeres are
also present in late S-phase cells. This study corroborates
pericentromeric H3S10 phosphorylation in G2 cells, and
demonstrates H3S10P persistence at pericentromeres
throughout the G2 phase (Fig. 2B). In addition, this study
supports the progressive appearance of histone H3S10
phosphorylation at increasing number of pericentromeres as
cells progress from S to G2 phase. Therefore, our results are
consistent with the view of pericentromeric H3S10P as a
physiological timeline initiating at a subset of pericentromeres
in late S-phase cells and completing at all pericentromere sites
in mid-to-late G2 cells (Zeitlin et al., 2001a).
To detail H3S10P foci progression, the selective appearance
at specific chromosomes was conducted by immuno-FISH
approaches. Arguing against stochastic phosphorylation at
random chromosomes, pericentromeres of chromosomes 1
and 9, containing the largest blocks of constitutive
heterochromatin in the human genome (Miller and Therman,
2000), are found to be positive for H3S10P foci 15 and 5
times, respectively, more frequently than expected for a
random model in NT2 cells (Fig. 3A,D). By contrast,
pericentromeres of chromosome 2, containing a small block
of heterochromatin, with the same satellite DNA family as
pericentromeres of chromosome 1 (Lee et al., 1997), were not
found to be any more frequently positive for H3S10P than
expected for a random model (Fig. 3B,D). Therefore, the DNA
sequence by itself cannot account for differential histone
phosphorylation frequencies at pericentromeres. Rather, the
size of pericentromeres modulates the number of
heterochromatin-specific modifications affecting histones and
DNA and could thereby promote preferential phosphorylation
at large pericentromeres.
Aur-B recruitment appears to be the dominant factor in the
chromosome-specific appearance of pericentromeric histone
H3 phosphorylation. Foci of histone H3S10P fail to appear in
interphase nuclei upon kinase inhibition by treatment with the
drug VX-680 (Fig. 1E-F). In addition, recruitment of Aur-B to
specific pericentromeres parallels that of focal H3S10P.
Indeed, Aur-B foci are found more frequently at large
pericentromeres than at small ones (Fig. 4B). Consistent with
the presence of an active Aurora-B kinase in late S and G2
nuclei, survivin and INCENP are detected at pericentromeres
of interphase nuclei with Aur-B (Fig. 4C-F), suggesting that an
activated Aur-B complex is recruited to pericentromeres.
The heterochromatic nature of large pericentromeres at the
time Aur-B was recruited and activated in interphase is
illustrated by the presence of methyl cytosines, methyl H3-K9
and HP1 (Fig. 5). However, in nuclei exhibiting several
H3S10P foci (around ten in NT2 cells), pericentromeres lose
labelling with HP1, a major heterochromatin marker (Fig.
5Be-h,D). This loss was not correlated with a change in the tri-
methylated form of H3-K9 – the HP1 binding site – as shown
by staining with an antibody directed against the doubly
modified H3K9me3-S10P (Fig. 5F). In agreement, we found
that depletion of DNMT1, with concomitant loss of
pericentromeric H3S10 phosphorylation, led to an increase in
the percentage of NT2 cells exhibiting HP1 (Fig. 7M). These
observations are consistent with the idea that pericentromeric
histone H3 phosphorylation promotes HP1 dissociation from
heterochromatin in interphase cells. Our results are in
agreement with the Aur-B-dependant HP1 dissociation
observed in mitotic cells by others (Fischle et al., 2005; Hirota
et al., 2005). In this respect, DNA methylation does not share
HP1 dynamics because it persists at large pericentromeres
throughout the G2 phase and mitosis (Fig. 5A).
With respect to the mechanism of demethylation-induced
suppression of pericentromeric histone H3 phosphorylation
two competing hypotheses can be considered. The first is that
genomic DNA demethylation induces changes in gene
expression patterns that compromise normal progression
through the cell cycle and thereby leads to defects in H3
phosphorylation during G2. The second is that local DNA
demethylation leads to a non-permissive environment that fails
to promote Aurora-B recruitment and H3 phosphorylation.
Two lines of evidence are consistent with the latter hypothesis.
Firstly, the quantitative distribution of cyclin B1, a major cell-
cycle regulator expressed in late S-G2, is unaffected by 5-AzaC
treatment (Fig. 6D-E). Secondly, the abundance of Aur-B in 5-
AzaC and DNMT1 AS-treated cells is very similar to control
cells (Fig. 6C, Fig. 7B, respectively), arguing against defects
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in the accumulation of the enzyme but rather in localization
and activity. These observations suggest that the G2 phase of
the cell cycle is grossly normal after hypomethylation,
supporting the interpretation that it is defects in
heterochromatin-associated DNA methylation that lead to
defects in Aurora-B targeting and pericentromeric histone H3
phosphorylation. Defects in H3 phosphorylation at
pericentromeres were previously reported in mammalian cells
where the histone methyl transferase SUV39H was either
overexpressed or deleted (Melcher et al., 2000). We propose
that histone H3K9 methylation and DNA methylation act
synergistically to regulate histone H3 phosphorylation at
pericentromeres of G2 cells. It was also shown that
perturbation of the hypoacetylated environment of
pericentromeres, by histone deacetylase inhibitors, resulted in
a decrease of Aur-B foci and of H3S10P foci (Robbins et al.,
2005), in agreement with a supporting role of histone
hypoacetylation in Aur-B recruitment. Thus, in addition to
these data indicating a role for H3K9 methylation in Aurora-
B recruitment, our results support an essential role for DNA
methylation in promoting Aur-B-induced histone H3
phosphorylation at pericentromeres of late S and G2 nuclei
(Figs 6, 7). Determining the precise mechanism through which
DNA methylation influences Aur-B recruitment to
pericentromeres will be a challenge for the future.
DNA methylation patterns are commonly altered in human
cancer cells (Laird and Jaenisch, 1996). Hypomethylation, a
hallmark of tumor cells, affects not only promoter gene
regions, but also very large genomic regions like
heterochromatic DNA repeats (Ehrlich, 2002). A causal role
for DNA hypomethylation in tumor formation was recently
shown, with the development of T-cell lymphomas in mice
carrying a hypomorphic Dnmt1 allele (Gaudet et al., 2003).
Therefore, DNA hypomethylation can be a leading cause of
tumorogenesis, although no mechanisms have been suggested
to explain the observed increase in chromosome instability
(Eden et al., 2003). We showed that DNA hypomethylation
inhibits Aur-B recruitment to interphase pericentromeres. As
in DNMT1-depleted cells, we found that Aur-B and H3S10P
foci are present with a very low frequency in the G2 fraction
of several tumor-derived cell lines exhibiting hypomethylated
satellite DNA (our unpublished data). Thus, Aur-B
mislocalization in interphase may be a contributing factor in
chromosome instability subsequent to DNA hypomethylation.
Therefore, deciphering the targeting mechanisms involved in
Aur-B recruitment to large methylated pericentromeres and
how these mechanisms are modified in transformed cells, will
yield important insight into cellular regulation of chromosome
function in G2 and mitosis.
Materials and Methods
Cell culture and flow cytometry analysis
NT2/D1 were cultured in DMEM supplemented with 10% foetal calf serum,
glutamine, non-essential amino acids and antibiotics. For immunofluorescence, cells
were grown on 12-mm coverslips for 1-2 days. For Aur-B inhibition, cells were
treated with 300 nM of VX-680 (Kava technology) for 24 hours. For BrdU
experiments a 40 M BrdU pulse was performed for 15 minutes and cells were
fixed immediately. Treatment with 10 M 5-azacytidine was performed for a total
of 24 hours. For cell-cycle analysis, exponentially growing cultures were fixed with
ethanol and stained with Hoechst 33258 at a concentration of 1 g/ml.
Determination of phases of the cell cycle was performed with the ModFit LT
software. For anti-sense experiments, NT2 cells were cultured to 50% confluency
and transfected for 24 hours with 90 nM of 44 hybrid 2-O-
methylphosphorothioate antisense (AS, MG88) and mismatched (MM, MG208)
oligonucleotides against human DNMT1 (Fournel et al., 1999), using Mirus TKO
reagent, according to the manufacturer’s instructions.
DNA probes and antibodies
Plasmid probes specific for pC1 [pUC 1.77 (Cooke and Hindley, 1979)], pC9
[pMR9a (Rocchi et al., 1991)] and pC14-22 [pZ13A (Archidiacono et al., 1995)]
were labelled by random priming with Biotin-dUTP (BioPrime, Gibco-BRL) or TR-
dUTP (Molecular Probes). pBS4D (Rocchi et al., 1990) was used to detect both
pC2 (major hybridization sites) and pC18-20 (minor hybridization sites).
Biotinylated probes and antibodies were detected with streptavidin-A488 (1:400,
Molecular Probes). Rabbit sera were used to detect phospho-histone H3S10 [1:300
for IF and 1:3000 for WB (Hendzel et al., 1997)], H3K9me3-S10P [1:500, (Fischle
et al., 2005)] and H3K9-me3 [1:1000 (Maison et al., 2002)], INCENP [1:1000
(Cooke et al., 1987)], DNMT1 [1:2500 for WB (Robert et al., 2003)] and a CREST
serum was used to detect centromeres (1:1000). The direct coupling of H3S10P
antibody with a modified form of Alexa Fluor A594 was performed to obtain
H3S10P-A594 according to the supplier’s instructions (Molecular Probes). Image-
iT FX signal enhancer (Molecular Probes) was used to replace the blocking buffer
and improve the signal to noise ratio when IF was performed with H3S10P-A594.
A biotinylated sheep polyclonal antibody was used to detect BrdU (1:200, Biodesign
int.). Monoclonal antibodies were used at the following dilutions: anti-Aur-B (1:100
for IF and 1:250 for WB, Transduction Labs), anti-5-meC (1:50), HP1 (1:4500,
Chemicon, clone 2HP-1H5, MAB3584) and anti-vimentin (1:2000 for WB, Sigma).
A goat antibody was used to detect survivin (1:100, Santa-Cruz). Secondary
antibodies were obtained from Jackson Immuno Research labs and Molecular
Probes.
FISH and immunofluorescence
Basic IF experiments were mainly performed as described previously (Sullivan et
al., 1994) and coverslips were mounted with Fluoromount G (EM Sciences)
containing 400 ng/ml DAPI. Peptide competition assays were performed by
incubating diluted antibodies with a 30 M concentration of modified histone H3
peptides (Upstate or Abcam) for 1 hour at 37°C. For BrdU detection, fixation was
performed in 2% paraformaldehyde (PFA) for 10 minutes followed by a 10-minute
step in cold methanol:PBS (9:1). Primary antibodies were incubated for 1 hour in
66 mM Tris, 0.66 mM MgCl2, 1 mM 2-mercaptoethanol, pH 8, containing 0.1%
Triton X-100 and 1.6 U/ml of DNAse. For 5-meC detection, cells were fixed in
PFA-methanol followed by a 10-minute 2N HCl treatment (de Capoa et al., 1996).
In order to maintain fluorescence intensities, H3S10P and centromeres were
detected before HCl treatment and post-fixed for 10 minutes in 2% PFA. Immuno-
FISH was performed in three steps: basic IF protocol, post-fixation for 10 minutes
in 2% PFA and FISH. The FISH procedure was mainly performed as described
(Solovei et al., 2002).
Microscopic image acquisition and analysis
Images of cells were obtained with a Delta-Vision wide-field optical sectioning
system, based on an Olympus IX70 epifluorescence microscope (Applied Precision,
Issaquah, WA). 100 (NA 1.35) or 40 (1.35 NA) neofluor oil-immersion lenses
were used with filters optimized to collect fluorescence emission for DAPI, FITC,
TR and Cy5 emissions. Alternatively, a motorized Zeiss Axioplan using a 63
objective lens (NA 1.4), equipped with a CoolSNAP HQ CCD camera driven by
Metamorph (Molecular Devices, v. 6.3) was used. Five to nine images were
collected at intervals of 0.2 to 0.3 m in the z axis for all cells. Image stacks were
processed using a 3D constrained iterative deconvolution algorithm (Softworx
analysis software, Applied Precision) or a 3D deconvolution procedure
(Metamorph) using the measured PSF. Three to five sections containing focused
signals were chosen for projection onto one plane for analysis. Projections were
further processed to generate digital masks using the magic wand and stroke tools
in Adobe® Photoshop to ease visualization of as many as four fluorescent channels.
Quantification on immuno-FISH images (Fig. 3D, Fig. 4B) was assessed as
follows. The number of protein and FISH signals were counted for each nucleus
analyzed. Colocalization of each FISH signal with phospho-H3 or Aur-B foci was
evaluated and scored independently of their colocalization extent. Quantification of
5-meC intensity was performed on single optical section containing the brightest
signal using a nucleus mask to assess the integrated intensity value with
morphometric tools in Metamorph. A normalization was performed with the
integrated intensity of a negative control population, where the HCl step was omitted
before immunodetection with 5-meC.
Electrophoresis and immunoblotting
Proteins were resolved by electrophoresis on SDS-PAGE gels (Laemmli, 1970),
transferred to PVDF membranes and immunoblotted as previously described
(Sullivan et al., 1994).
We acknowledge Fabienne Simian-Lermé and Chantal Bella, heads
of the PLATIM Microscopy and Flow Cytometry facilities of the IFR
128 (Lyon, France), respectively. We thank Ana Angulo for kind gift
Journal of Cell Science 120 (1)
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
113DNA methylation promotes Aurora-B targeting
of the NT2/D1 cell line. We thank Dave Allis for kind gift of H3S10P
antibody and H3K9me3-S10P peptide, Thomas Jenuwein for kind gift
of H3K9-me3 antibody, Robert Mac Leod for kind gift of DNMT1
antibody, William C. Earnshaw for kind gift of INCENP antibody and
Alain Niveleau for kind gift of 5-meC antibody. K.M. was supported
by a fellowship from the Rett Syndrome Research Foundation (RSRF)
and from the Foundations Groupama pour la Sante and la Recherche
Médicale (FRM). Work in the K.M. laboratory was supported by the
Ligue contre le Cancer, Comité du Rhône. Work in the K.F.S.
laboratory was supported by the NIH (RO1 GM39068) and a grant
from Science Foundation Ireland. Authors thank Sam Zeitlin for
critical reading of the manuscript.
References
Aagaard, L., Laible, G., Selenko, P., Schmid, M., Dorn, R., Schotta, G., Kuhfittig, S.,
Wolf, A., Lebersorger, A., Singh, P. B. et al. (1999). Functional mammalian
homologues of the Drosophila PEV-modifier Su(var)3-9 encode centromere-associated
proteins which complex with the heterochromatin component M31. EMBO J. 18, 1923-
1938.
Adams, R. R., Carmena, M. and Earnshaw, W. C. (2001). Chromosomal passengers
and the (aurora) ABCs of mitosis. Trends Cell Biol. 11, 49-54.
Andrews, P. D. (2005). Aurora kinases: shining lights on the therapeutic horizon?
Oncogene 24, 5005-5015.
Andrews, P. D., Knatko, E., Moore, W. J. and Swedlow, J. R. (2003). Mitotic
mechanics: the auroras come into view. Curr. Opin. Cell Biol. 15, 672-683.
Archidiacono, N., Antonacci, R., Marzella, R., Finelli, P., Lonoce, A. and Rocchi, M.
(1995). Comparative mapping of human alphoid sequences in great apes using
fluorescence in situ hybridization. Genomics 25, 477-484.
Bannister, A. J. and Kouzarides, T. (2005). Reversing histone methylation. Nature 436,
1103-1106.
Berger, S. L. (2001). An embarrassment of niches: the many covalent modifications of
histones in transcriptional regulation. Oncogene 20, 3007-3013.
Bolton, M. A., Lan, W., Powers, S. E., McCleland, M. L., Kuang, J. and Stukenberg,
P. T. (2002). Aurora B kinase exists in a complex with survivin and INCENP and its
kinase activity is stimulated by survivin binding and phosphorylation. Mol. Biol. Cell
13, 3064-3077.
Cooke, C. A., Heck, M. M. and Earnshaw, W. C. (1987). The inner centromere protein
(INCENP) antigens: movement from inner centromere to midbody during mitosis. J.
Cell Biol. 105, 2053-2067.
Cooke, H. J. and Hindley, J. (1979). Cloning of human satellite III DNA: different
components are on different chromosomes. Nucleic Acids Res. 6, 3177-3197.
Crosio, C., Fimia, G. M., Loury, R., Kimura, M., Okano, Y., Zhou, H., Sen, S.,
Allis, C. D. and Sassone-Corsi, P. (2002). Mitotic phosphorylation of histone H3:
spatio-temporal regulation by mammalian Aurora kinases. Mol. Cell. Biol. 22, 874-
885.
de Capoa, A., Menendez, F., Poggesi, I., Giancotti, P., Grappelli, C., Marotta, M. R.,
Di Leandro, M., Reynaud, C. and Niveleau, A. (1996). Cytological evidence for 5-
azacytidine-induced demethylation of the heterochromatic regions of human
chromosomes. Chromosome Res. 4, 271-276.
Ducat, D. and Zheng, Y. (2004). Aurora kinases in spindle assembly and chromosome
segregation. Exp. Cell Res. 301, 60-67.
Earnshaw, W. C. and Bernat, R. L. (1991). Chromosomal passengers: toward an
integrated view of mitosis. Chromosoma 100, 139-146.
Eden, A., Gaudet, F., Waghmare, A. and Jaenisch, R. (2003). Chromosomal instability
and tumors promoted by DNA hypomethylation. Science 300, 455.
Ehrlich, M. (2002). DNA methylation in cancer: too much, but also too little. Oncogene
21, 5400-5413.
Fischle, W., Wang, Y. and Allis, C. D. (2003). Histone and chromatin cross-talk. Curr.
Opin. Cell Biol. 15, 172-183.
Fischle, W., Tseng, B. S., Dormann, H. L., Ueberheide, B. M., Garcia, B. A.,
Shabanowitz, J., Hunt, D. F., Funabiki, H. and Allis, C. D. (2005). Regulation of
HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature 438,
1116-1122.
Fournel, M., Sapieha, P., Beaulieu, N., Besterman, J. M. and MacLeod, A. R. (1999).
Down-regulation of human DNA-(cytosine-5) methyltransferase induces cell cycle
regulators p16(ink4A) and p21(WAF/Cip1) by distinct mechanisms. J. Biol. Chem.
274, 24250-24256.
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W.,
Leonhardt, H. and Jaenisch, R. (2003). Induction of tumors in mice by genomic
hypomethylation. Science 300, 489-492.
Giet, R. and Glover, D. M. (2001). Drosophila aurora B kinase is required for histone
H3 phosphorylation and condensin recruitment during chromosome condensation and
to organize the central spindle during cytokinesis. J. Cell Biol. 152, 669-682.
Hall, I. M., Noma, K. and Grewal, S. I. (2003). RNA interference machinery regulates
chromosome dynamics during mitosis and meiosis in fission yeast. Proc. Natl. Acad.
Sci. USA 100, 193-198.
Harrington, E. A., Bebbington, D., Moore, J., Rasmussen, R. K., Ajose-Adeogun, A.
O., Nakayama, T., Graham, J. A., Demur, C., Hercend, T., Diu-Hercend, A. et al.
(2004). VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases,
suppresses tumor growth in vivo. Nat. Med. 10, 262-267.
Hendzel, M. J., Wei, Y., Mancini, M. A., Van Hooser, A., Ranalli, T., Brinkley, B. R.,
Bazett-Jones, D. P. and Allis, C. D. (1997). Mitosis-specific phosphorylation of
histone H3 initiates primarily within pericentromeric heterochromatin during G2 and
spreads in an ordered fashion coincident with mitotic chromosome condensation.
Chromosoma 106, 348-360.
Hirota, T., Lipp, J. J., Toh, B. H. and Peters, J. M. (2005). Histone H3 serine 10
phosphorylation by Aurora B causes HP1 dissociation from heterochromatin. Nature
438, 1176-1180.
Honda, R., Korner, R. and Nigg, E. A. (2003). Exploring the functional interactions
between Aurora B, INCENP, and survivin in mitosis. Mol. Biol. Cell 14, 3325-3341.
Hsu, J. Y., Sun, Z. W., Li, X., Reuben, M., Tatchell, K., Bishop, D. K., Grushcow, J.
M., Brame, C. J., Caldwell, J. A., Hunt, D. F. et al. (2000). Mitotic phosphorylation
of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding
yeast and nematodes. Cell 102, 279-291.
Lachner, M., O’Carroll, D., Rea, S., Mechtler, K. and Jenuwein, T. (2001).
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410,
116-120.
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head
of bacteriophage T4. Nature 227, 680-685.
Laird, P. W. and Jaenisch, R. (1996). The role of DNA methylation in cancer genetic
and epigenetics. Annu. Rev. Genet. 30, 441-464.
Lavelle, D., DeSimone, J., Hankewych, M., Kousnetzova, T. and Chen, Y. H. (2003).
Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M
phase via the p38 MAP kinase pathway. Leuk. Res. 27, 999-1007.
Lee, C., Wevrick, R., Fisher, R. B., Ferguson-Smith, M. A. and Lin, C. C. (1997).
Human centromeric DNAs. Hum. Genet. 100, 291-304.
Li, E. (2002). Chromatin modification and epigenetic reprogramming in mammalian
development. Nat. Rev. Genet. 3, 662-673.
Maison, C., Bailly, D., Peters, A. H., Quivy, J. P., Roche, D., Taddei, A., Lachner, M.,
Jenuwein, T. and Almouzni, G. (2002). Higher-order structure in pericentric
heterochromatin involves a distinct pattern of histone modification and an RNA
component. Nat. Genet. 30, 329-334.
Melcher, M., Schmid, M., Aagaard, L., Selenko, P., Laible, G. and Jenuwein, T.
(2000). Structure-function analysis of SUV39H1 reveals a dominant role in
heterochromatin organization, chromosome segregation, and mitotic progression. Mol.
Cell. Biol. 20, 3728-3741.
Mellone, B. G., Ball, L., Suka, N., Grunstein, M. R., Partridge, J. F. and Allshire, R.
C. (2003). Centromere silencing and function in fission yeast is governed by the amino
terminus of histone H3. Curr. Biol. 13, 1748-1757.
Meraldi, P., Honda, R. and Nigg, E. A. (2004). Aurora kinases link chromosome
segregation and cell division to cancer susceptibility. Curr. Opin. Genet. Dev. 14, 29-
36.
Miller, O. J. and Therman, E. (2000). Human Chromosomes. New York: Springer.
Ota, T., Suto, S., Katayama, H., Han, Z. B., Suzuki, F., Maeda, M., Tanino, M.,
Terada, Y. and Tatsuka, M. (2002). Increased mitotic phosphorylation of histone H3
attributable to AIM-1/Aurora-B overexpression contributes to chromosome number
instability. Cancer Res. 62, 5168-5177.
Pines, J. and Hunter, T. (1991). Human cyclins A and B1 are differentially located
in the cell and undergo cell cycle-dependent nuclear transport. J. Cell Biol. 115, 1-
17.
Pines, J. and Hunter, T. (1992). Cyclins A and B1 in the human cell cycle. Ciba Found.
Symp. 170, 187-196; discussion 196-204.
Rea, S., Eisenhaber, F., O’Carroll, D., Strahl, B. D., Sun, Z. W., Schmid, M., Opravil,
S., Mechtler, K., Ponting, C. P., Allis, C. D. et al. (2000). Regulation of chromatin
structure by site-specific histone H3 methyltransferases. Nature 406, 593-599.
Richards, E. J. and Elgin, S. C. (2002). Epigenetic codes for heterochromatin formation
and silencing: rounding up the usual suspects. Cell 108, 489-500.
Robbins, A. R., Jablonski, S. A., Yen, T. J., Yoda, K., Robey, R., Bates, S. E. and
Sackett, D. L. (2005). Inhibitors of histone deacetylases alter kinetochore assembly
by disrupting pericentromeric heterochromatin. Cell Cycle 4, 717-726.
Robert, M. F., Morin, S., Beaulieu, N., Gauthier, F., Chute, I. C., Barsalou, A. and
MacLeod, A. R. (2003). DNMT1 is required to maintain CpG methylation and
aberrant gene silencing in human cancer cells. Nat. Genet. 33, 61-65.
Rocchi, M., Baldini, A., Archidiacono, N., Lainwala, S., Miller, O. J. and Miller, D.
A. (1990). Chromosome-specific subsets of human alphoid DNA identified by a
chromosome 2-derived clone. Genomics 8, 705-709.
Rocchi, M., Archidiacono, N., Ward, D. C. and Baldini, A. (1991). A human
chromosome 9-specific alphoid DNA repeat spatially resolvable from satellite 3 DNA
by fluorescent in situ hybridization. Genomics 9, 517-523.
Scrittori, L., Skoufias, D. A., Hans, F., Gerson, V., Sassone-Corsi, P., Dimitrov, S. and
Margolis, R. L. (2005). A small C-terminal sequence of Aurora B is responsible for
localization and function. Mol. Biol. Cell 16, 292-305.
Shannon, K. B. and Salmon, E. D. (2002). Chromosome dynamics: new light on Aurora
B kinase function. Curr. Biol. 12, R458-R460.
Shelby, R. D., Monier, K. and Sullivan, K. F. (2000). Chromatin assembly at
kinetochores is uncoupled from DNA replication. J. Cell Biol. 151, 1113-1118.
Solovei, I., Cavallo, A., Schermelleh, L., Jaunin, F., Scasselati, C., Cmarko, D.,
Cremer, C., Fakan, S. and Cremer, T. (2002). Spatial preservation of nuclear
chromatin architecture during three-dimensional fluorescence in situ hybridization
(3D-FISH). Exp. Cell Res. 276, 10-23.
Strahl, B. D. and Allis, C. D. (2000). The language of covalent histone modifications.
Nature 403, 41-45.
Sugiyama, T., Cam, H., Verdel, A., Moazed, D. and Grewal, S. I. (2005). RNA-
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
114
dependent RNA polymerase is an essential component of a self-enforcing loop
coupling heterochromatin assembly to siRNA production. Proc. Natl. Acad. Sci. USA
102, 152-157.
Sullivan, K. F., Hechenberger, M. and Masri, K. (1994). Human CENP-A contains a
histone H3 related histone fold domain that is required for targeting to the centromere.
J. Cell Biol. 127, 581-592.
Taddei, A., Maison, C., Roche, D. and Almouzni, G. (2001). Reversible disruption of
pericentric heterochromatin and centromere function by inhibiting deacetylases. Nat.
Cell Biol. 3, 114-120.
Vagnarelli, P. and Earnshaw, W. C. (2004). Chromosomal passengers: the four-
dimensional regulation of mitotic events. Chromosoma 113, 211-222.
Wade, P. A. (2001). Methyl CpG-binding proteins and transcriptional repression.
BioEssays 23, 1131-1137.
Wei, Y., Yu, L., Bowen, J., Gorovsky, M. A. and Allis, C. D. (1999). Phosphorylation
of histone H3 is required for proper chromosome condensation and segregation. Cell
97, 99-109.
Wheatley, S. P., Henzing, A. J., Dodson, H., Khaled, W. and Earnshaw, W. C. (2004).
Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for
its localization and binding to inner centromere protein (INCENP) in vivo. J. Biol.
Chem. 279, 5655-5660.
Zeitlin, S. G., Monier, K. and Sullivan, K. F. (2001a). Phospho-histone antibody
immunofluorescence for analysis of cell cycle progression in G2 and prophase.
Chemtracts Biochem. Mol. Biol. 14, 557-562.
Zeitlin, S. G., Shelby, R. D. and Sullivan, K. F. (2001b). CENP-A is phosphorylated by
Aurora B kinase and plays an unexpected role in completion of cytokinesis. J. Cell
Biol. 155, 1147-1157.
Journal of Cell Science 120 (1)
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
